<DOC>
	<DOCNO>NCT01016834</DOCNO>
	<brief_summary>The purpose study evaluate treatment satisfaction subject use Sumavel DosePro treat moderate severe migraine .</brief_summary>
	<brief_title>Evaluation Treatment Satisfaction Preference Sumavel DosePro Treatment Migraine</brief_title>
	<detailed_description>Single arm , open-label , multicenter study evaluate treatment satisfaction , treatment confidence , subject preference Sumavel DosePro adult subject diagnose migraine currently treat triptans . Subjects treat 4 migraine 60 day period complete migraine diary questionnaire .</detailed_description>
	<mesh_term>Migraine Disorders</mesh_term>
	<mesh_term>Sumatriptan</mesh_term>
	<criteria>History 2 6 migraine headache per month Migraines present least 1 year age onset migraine le 50 year History 24 hour freedom migraine attack Current user triptan medication Able distinguish interval nonmigrainous headache typical migraine General good health History symptom , sign ischemic cardiac , cerebrovascular , peripheral vascular syndrome Significant underlying cardiovascular disease include uncontrolled hypertension Hemiplegic basilar migraine History diagnosis severe hepatic renal impairment History epilepsy seizure serious neurologic condition History allergy , anaphylaxis , hypersensitivity sumatriptan component similar drug include sulphonamides History scleroderma ( systemic sclerosis ) Pregnant breastfeeding Use contraindicate prescription medication , monoamine oxidase inhibitor ( MAOA ) , selective serotonin reuptake inhibitor , lithium agent</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>November 2011</verification_date>
	<keyword>migraine</keyword>
	<keyword>treatment satisfaction</keyword>
</DOC>